Blood coagulation assays indicated that functionalized magnetic composites did not induce thrombogenic reactions in contact with blood.
Deficiencies in these proteins are often undiagnosed for decades and detected later in life during routine coagulation assays without an apparent clinical phenotype.
In contrast to standard coagulation assays, these biomarkers use unadulterated whole blood and are measured immediately at the bedside.
These results demonstrated the applicability of the combination of GPC, PAGE, and coagulation assays to characterize the molecular and biochemical profile of HDO.
DOACs require particular coagulation assays to measure anticoagulation levels accurately, although standard coagulation screening tests may provide qualitative guidance.
Coagulation assays indicated that ADPs-1b, ADPs-2, ADPs-3a and ADPs-3b had procoagulant activities.
For coagulation assays, blood (four parts) was collected in tubes containing 3.8% sodium citrate (one part).
In animal models, there was an improvement in bleeding time, but there was no effect on the coagulation assays [9,10].
Coagulation assays indicated that LLp-1a and LLp-3 had good anticoagulant effect in vitro, while LLp-1b showed procoagulant activity.
Coagulation assays in vitro indicated that ADPs-1b, ADPs-2, ADPs-3a and ADPs-3b had the procoagulant activity, The results imply that polysaccharides from A. dahuricae Radix has promising propects as hemostatics in medicines.
After comparing the aPTT, endogenous thrombin potential (ETP), lag time, TT, and ECT in all the subjects, the administration of the 4 F-PCC had no influence on these coagulation assays for the patients receiving dabigatran [14].
